Clarke P, Murchan S, Smyth E G, Humphreys H
Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Education and Research Centre, Dublin, Ireland.
Clin Microbiol Infect. 2004 Jul;10(7):657-9. doi: 10.1111/j.1469-0691.2004.00894.x.
Between January 1999 and June 2002, 646 invasive isolates of Streptococcus pneumoniae were collected in Ireland. MICs of penicillin, ciprofloxacin, cefotaxime, moxifloxacin and linezolid were determined by Etest methodology. Eighty-seven (13.5%) isolates showed intermediate resistance to penicillin, while seven (1.1%) showed high-level resistance. Eighty-seven (13.5%) isolates were resistant to erythromycin, but all isolates were susceptible to cefotaxime, moxifloxacin and linezolid. The prevalence of pneumococcal isolates non-susceptible to penicillin in Ireland is worryingly high, but currently there are alternative agents available to treat invasive infection.
1999年1月至2002年6月期间,爱尔兰收集了646株肺炎链球菌侵袭性分离株。采用Etest方法测定了青霉素、环丙沙星、头孢噻肟、莫西沙星和利奈唑胺的最低抑菌浓度(MIC)。87株(13.5%)分离株对青霉素呈中度耐药,7株(1.1%)呈高度耐药。87株(13.5%)分离株对红霉素耐药,但所有分离株对头孢噻肟、莫西沙星和利奈唑胺敏感。爱尔兰肺炎链球菌分离株对青霉素不敏感的患病率高得令人担忧,但目前有其他药物可用于治疗侵袭性感染。